H. Schoemans

ECP versus ruxolitinib in steroid-refractory acute GVHD – a retrospective study by the EBMT transplant complications working party

J. Pérez-Simón, Z. Perić, Z. Ozkurt, 2023, Frontiers in Immunology.

Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study.

U. Salmenniemi, E. Forcade, Z. Perić, 2023, Bone marrow transplantation.

International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.

N. Chaudhri, Z. Perić, N. Majhail, 2024, Bone marrow transplantation.

International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update

N. Chaudhri, Z. Perić, N. Majhail, 2023, Transplantation and cellular therapy.

PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation

P. Dreger, Z. Perić, T. Gedde-Dahl, 2024, Blood cancer journal.

Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.

M. Mohty, F. Bonifazi, Z. Perić, 2024, The Lancet. Haematology.